MTRE, recently acquired by Belmont Instrument LLC, is a medical technology company that develops, manufactures and markets Innovative non-invasive solutions for body temperature control. MTRE presents novel, revolutionary Innovative non-invasive solutions that enable healthcare providers to exercise precise and timely control of body temperature, thereby paving the way for significant medical and economical benefits. The product lines target a wide range of medical applications and disciplines, including the evolving applications of Neuroprotective Cooling Therapy for cardiac arrest; asphyxia and Traumatic Brain Injury (TBI) victims as well as cardio-vascular, organ transplant, pediatric, neurosurgery, and trauma.
Belmont Instrument, LLC announced it has acquired MTRE Ltd. product lines from Mennen Medical Ltd. Belmont’s acquisition of MTRE extends its portfolio to include non-invasive body temperature management solutions and advances Belmont’s strategy to invest in technologies that leverage the company’s existing product portfolio and sales channels.
For more information about Belmont and its products, please visit www.belmontinstrument.com.